NeoTract Announces Data from Large Real-World Study of UroLift® System, Confirming Positive Results for Company’s Treatment for Enlarged Prostate
March 20, 2018
PLEASANTON, Calif. – March 19, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in...
Read MoreTeleflex Incorporated Completes Acquisition of Neotract
October 2, 2017
Contact: Jake Elguicze Treasurer and Vice President of Investor Relations 610-948-2836
Read MoreTeleflex Incorporated to Acquire NeoTract
September 5, 2017
FOR IMMEDIATE RELEASE September 5, 2017
Read MoreNeoTract Inc. Announces Cigna Coverage for the UroLift® System for Enlarged Prostate
May 11, 2017
PLEASANTON, Calif.– May 11, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today...
Read MoreNeoTract Inc. Announces Presentations of Multiple Clinical Studies Featuring Five-Year Data from Pivotal Randomized Trial of UroLift® System at American Urological Association 2017 Meeting
May 8, 2017
PLEASANTON, Calif.– May 8, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced...
Read MoreNeoTract Inc. Receives #Gamechanger Award for Innovation
April 17, 2017
PLEASANTON, Calif.– April 13, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, announced...
Read MoreNeoTract’s Minimally Invasive UroLift® System for Enlarged Prostate Now Shown to be Durable Through Five Years: Results from Pivotal L.I.F.T. Randomized Study Presented
March 27, 2017
PLEASANTON, Calif. and LONDON – March 27, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology,...
Read MoreRevolutionary UroLift® System Launches in Ireland
March 24, 2017
PLEASANTON, CA, US March 23, 2017 - NeoTract, Inc., announced today that the largest private health insurer in Ireland, Vhi Group, is to reimburse...
Read MoreNeoTract’s UroLift® System Featured in the American Urological Association’s Urology Residents BPH/LUTS Training Program
March 21, 2017
PLEASANTON, Calif. – March 21, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, announced...
Read MoreNeoTract Convenes Leading Urologists for Summit on Treating Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms
February 27, 2017
PLEASANTON, Calif. – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, recently hosted more than 60...
Read More
